ELAVL1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the contrary, lncRNA FENDRR downregulates MDR1 expression via sponging miR-184 and RNA binding protein HuR, thus reversing resistance of CML cells to doxorubicin (Zhang et al., 2019).